Articles in Life Sciences

License Practitioners Beware the Macom Imbroglio!

Posted

Business and legal professionals beware of your Field of Use restrictions. Practitioners involved in constructing and drafting license agreements should pay particular attention to a U.S. Court of Appeals case decided in the Central District of California, Macom Technology Solutions Holdings, Inc. v. Infineon Technologies AG (January 29, 2018).  In the Macom case, the licensor Infineon sought to terminate a license agreement with its Read More

More Money for Life Sciences?

Posted

A new legislative proposal to provide a five-year, $500 million life sciences initiative was recently announced by Governor Charlie Baker. This initiative would extend the current 10-year, $1 billion initiative that is set to expire at the end of the next fiscal year and would continue to be managed by the Massachusetts Life Sciences Center. The proposal includes $295 million Read More

Wait a Minute Mr. Postman… How To Respond To a Demand Letter for Life Sciences Companies

Posted

Sooner or later many companies with a successful product or service will receive an overture from a patent holder. Some are almost friendly, proposing a potential mutually beneficial business relationship involving the patent. Others are decidedly less so, leveling claims of patent infringement and seeking immediate termination of the activity or product sales and/or significant financial compensation. This entire range Read More

Supreme Court Denies Sequenom’s Petition to Clarify Scope of Mayo in Sequenom v. Ariosa

Posted

On June 27, 2016, the United States Supreme Court denied a Petition for Writ of Certiorari filed by Sequenom, Inc. requesting the Supreme Court to clarify the scope of its Mayo Collaborative Services v. Prometheus Laboratories, Inc., 132 S. Ct. 1289 (2012) decision, as applied to Sequenom’s claimed inventions.  The Mayo decision, which held that a method correlating a drug Read More